News
Marriott Looks to Strategic Innovation for Future Gains
Companies are always looking for ways to grow, and Marriott International (NASDAQ: MAR) hasn't hesitated to make key strategic moves when the time was right. After acquiring Starwood Hotels & Resorts
Marriott Looks to Strategic Innovation for Future Gains
Companies are always looking for ways to grow, and Marriott International (NASDAQ: MAR) hasn't hesitated to make key strategic moves when the time was right. After acquiring Starwood Hotels & Resorts
Tesla, Inc. Lowers the Price for Its Model X
On Friday, Tesla (NASDAQ: TSLA) lowered the price of the base version of its Model X SUV by $3,000, from $82,500 to $79,500. The price decrease puts the SUV's starting price just $5,000 above a
Tesla, Inc. Lowers the Price for Its Model X
On Friday, Tesla (NASDAQ: TSLA) lowered the price of the base version of its Model X SUV by $3,000, from $82,500 to $79,500. The price decrease puts the SUV's starting price just $5,000 above a
What's Behind TG Therapeutics Inc.'s 14.4% Rally in July?
Shares of TG Therapeutics Inc. (NASDAQ: TGTX) gained 14.4% in July, according to data from S&P Global Market Intelligence, despite a lack of positive announcements. It doesn't take much to move a
What's Behind TG Therapeutics Inc.'s 14.4% Rally in July?
Shares of TG Therapeutics Inc. (NASDAQ: TGTX) gained 14.4% in July, according to data from S&P Global Market Intelligence, despite a lack of positive announcements. It doesn't take much to move a
5 Things Encana Corp's CEO Wants You to Know That Demonstrate Its Ability to Thrive at Current Prices
Encana (NYSE: ECA) recently reported blowout second-quarter results. Heading into the quarter, analysts expected that it would earn $0.04 per share. However, it blew past that estimate by posting a
Why On Deck Capital Stock Jumped More Than 20% on Monday
Shares of On Deck Capital (NYSE: ONDK) were up more than 21% as of 3:15 p.m. EDT, after the company announced a smaller net loss during the second quarter and a promising expansion in its partnership
Why On Deck Capital Stock Jumped More Than 20% on Monday
Shares of On Deck Capital (NYSE: ONDK) were up more than 21% as of 3:15 p.m. EDT, after the company announced a smaller net loss during the second quarter and a promising expansion in its partnership
Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today
The stock market kept climbing on Monday, with modest gains across major benchmarks that nevertheless sent the Dow Jones Industrial Average to its ninth straight record high. Absent major news in the
Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today
The stock market kept climbing on Monday, with modest gains across major benchmarks that nevertheless sent the Dow Jones Industrial Average to its ninth straight record high. Absent major news in the
Here's Why Array BioPharma Inc. Fell 13.7% in July
Shares of Array BioPharma (NASDAQ: ARRY), a cancer-focused clinical-stage biotech, dropped nearly 14% in July, according to data from S&P Global Market Intelligence.Here's a review of the two company
Here's Why Array BioPharma Inc. Fell 13.7% in July
Shares of Array BioPharma (NASDAQ: ARRY), a cancer-focused clinical-stage biotech, dropped nearly 14% in July, according to data from S&P Global Market Intelligence.Here's a review of the two company
Here's Why Array BioPharma Inc. Fell 13.7% in July
Shares of Array BioPharma (NASDAQ: ARRY), a cancer-focused clinical-stage biotech, dropped nearly 14% in July, according to data from S&P Global Market Intelligence.Here's a review of the two company
What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of Pacific Biosciences of California (NASDAQ: PACB) are on the rise again. This is the third trading session in a row that the stock has marched upwards since announcing record revenues and a
Here's Why Apple Inc.'s OLED iPhone 8 Won't Include Touch ID
For the last month or so, there has been a lot of drama surrounding Apple's (NASDAQ: AAPL) upcoming premium OLED iPhone. The device had long been expected to include an in-display fingerprint scanner
Here's Why Apple Inc.'s OLED iPhone 8 Won't Include Touch ID
For the last month or so, there has been a lot of drama surrounding Apple's (NASDAQ: AAPL) upcoming premium OLED iPhone. The device had long been expected to include an in-display fingerprint scanner
Here's Why Apple Inc.'s OLED iPhone 8 Won't Include Touch ID
For the last month or so, there has been a lot of drama surrounding Apple's (NASDAQ: AAPL) upcoming premium OLED iPhone. The device had long been expected to include an in-display fingerprint scanner
Here's Why Apple Inc.'s OLED iPhone 8 Won't Include Touch ID
For the last month or so, there has been a lot of drama surrounding Apple's (NASDAQ: AAPL) upcoming premium OLED iPhone. The device had long been expected to include an in-display fingerprint scanner
How MobileIron Inc. Stock Fell 25% in July
Shares of MobileIron (NASDAQ: MOBL) fell 25.2% in July, according to data from S&P Global Market Intelligence.The maker of mobile data security tools for enterprise-class customers reported
Twitter's MAU Blues and Apple's New Highs
Two of the biggest names in tech recently reported their earnings and saw very different reactions from the market. While Apple's (NASDAQ: AAPL) earnings and guidance were incredibly strong, what few
Twitter's MAU Blues and Apple's New Highs
Two of the biggest names in tech recently reported their earnings and saw very different reactions from the market. While Apple's (NASDAQ: AAPL) earnings and guidance were incredibly strong, what few
Twitter's MAU Blues and Apple's New Highs
Two of the biggest names in tech recently reported their earnings and saw very different reactions from the market. While Apple's (NASDAQ: AAPL) earnings and guidance were incredibly strong, what few
Twitter's MAU Blues and Apple's New Highs
Two of the biggest names in tech recently reported their earnings and saw very different reactions from the market. While Apple's (NASDAQ: AAPL) earnings and guidance were incredibly strong, what few
bluebird bio Pauses During 2017 Data Blitz
Clinical-stage gene therapy specialist bluebird bio (NASDAQ: BLUE) reported second-quarter earnings last week, which mostly just served as a reminder of its pipeline progress because revenue and